To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)
Clinical trial NCT02326155 · TERMINATED
Trial details
- NCT number
- NCT02326155
- Sponsor
- Celltrion
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2014-12-08
- Primary completion
- 2020-02-28
- Enrollment
- 470
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.